Creative Planning
RXST icon

Creative Planning’s RxSight RXST Stock Holding History

Creative Planning’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$236K Sell
38,325
-69,512
-64% -$577K ﹤0.01% 3615
2025
Q4 		$1.12M Buy
107,837
+8,579
+9% +$86.1K ﹤0.01% 2190
2025
Q3 		$892K Buy
99,258
+83,341
+524% +$731K ﹤0.01% 2208
2025
Q2 		$207K Buy
+15,917
New +$239K ﹤0.01% 3194
2025
Q1 		– Sell
-41
Closed -$1.41K – 3686
2024
Q4 		$1.41K Buy
+41
New +$1.85K ﹤0.01% 3499

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Creative Planning's RXST Position: Q1 2026 in Review

Creative Planning reduced its RxSight (RXST) stake by 64% in Q1 2026, selling an estimated $577K and leaving 38,325 shares worth $236K. The position accounts for ﹤0.01% of the portfolio, ranked #3615.

Creative Planning first reported a position in RXST in Q4 2024 and has held it in 5 quarters since. The position peaked at $1.12M in Q4 2025. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Creative Planning held 38,325 shares of RxSight worth $236K as of Q1 2026.
  • Creative Planning sold 69,512 RxSight shares in Q1 2026, an estimated $577K.
  • RxSight made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #3615 holding.
  • Creative Planning first reported a position in RxSight in Q4 2024 and has held it in 5 quarters since.
  • Creative Planning's RxSight position peaked at $1.12M in Q4 2025.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.